Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study
- PMID: 12164590
- DOI: 10.1088/0031-9155/47/13/310
Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study
Abstract
An x-ray fluorescence system with a synchrotron radiation source was used to quantify the levels of iron, copper and zinc in breast tissue specimens. Healthy tissue and breast carcinomas were investigated as an aid to understanding the mechanisms of breast cancer and as a possible complementary diagnostic tool. Eighty samples were measured in total. Twenty samples were matched pairs, i.e. 20 tumour samples with 20 corresponding healthy tissue specimens taken at a distance from the tumour. The remaining 40 samples consisted of 20 excised tumours and 20 healthy specimens from breast reduction surgeries. The levels of the elements of interest were quantified via calibration models constructed using the XRF response from standard solutions. The statistical analysis of the results indicates elevation of the levels of all three trace elements in the tumours. The effect is more prominent for copper and zinc while the contrast between healthy and diseased tissue is enhanced when comparing the independent specimens rather than the paired samples. Specifically, the ratio of mean tumour to mean healthy concentration for iron was 1.6 for the paired samples and 2.7 for the non-paired samples. The ratios describing copper content were 3.1 for paired and 3.6 for non-paired samples while for zinc they were 2.4 and 4.4 respectively.
Similar articles
-
The localisation and micro-mapping of copper and other trace elements in breast tumours using a synchrotron micro-XRF system.Appl Radiat Isot. 2007 Feb;65(2):183-8. doi: 10.1016/j.apradiso.2006.08.013. Epub 2006 Oct 18. Appl Radiat Isot. 2007. PMID: 17052909
-
The evaluation of biologically important trace metals in liver, kidney and breast tissue.Appl Radiat Isot. 2009 Mar;67(3):470-4. doi: 10.1016/j.apradiso.2008.06.018. Epub 2008 Jun 22. Appl Radiat Isot. 2009. PMID: 18675548
-
Trace elements as tumor biomarkers and prognostic factors in breast cancer: a study through energy dispersive x-ray fluorescence.BMC Res Notes. 2012 Jul 6;5:194. doi: 10.1186/1756-0500-5-194. BMC Res Notes. 2012. PMID: 22534013 Free PMC article.
-
Elemental imaging of trace elements in bone samples using micro and nano-X-ray fluorescence spectrometry.Appl Radiat Isot. 2019 Jul;149:200-205. doi: 10.1016/j.apradiso.2019.04.033. Epub 2019 Apr 30. Appl Radiat Isot. 2019. PMID: 31077976 Review.
-
Trace element concentrations studied in vivo using X-ray fluorescence analysis.Appl Radiat Isot. 1998 May-Jun;49(5-6):437-45. doi: 10.1016/s0969-8043(97)00264-9. Appl Radiat Isot. 1998. PMID: 9569512 Review. No abstract available.
Cited by
-
Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II.Cancers (Basel). 2020 Oct 5;12(10):2863. doi: 10.3390/cancers12102863. Cancers (Basel). 2020. PMID: 33027952 Free PMC article. Review.
-
Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action.Molecules. 2021 Dec 22;27(1):49. doi: 10.3390/molecules27010049. Molecules. 2021. PMID: 35011273 Free PMC article. Review.
-
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.Drug Des Devel Ther. 2013 Oct 4;7:1157-78. doi: 10.2147/DDDT.S49763. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24115839 Free PMC article. Review.
-
Serum Levels of Copper and Zinc and Survival in Breast Cancer Patients.Nutrients. 2024 Mar 29;16(7):1000. doi: 10.3390/nu16071000. Nutrients. 2024. PMID: 38613033 Free PMC article.
-
A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.Pharmaceutics. 2024 Dec 18;16(12):1610. doi: 10.3390/pharmaceutics16121610. Pharmaceutics. 2024. PMID: 39771588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical